The immune response to p53 in breast cancer patients is directed against immunodominant epitopes unrelated to the mutational hot spot.

作者: Yann Legros , David Lane , Beata Schlichtholz , Fabien Calvo , Michel Marty

DOI:

关键词:

摘要: Alteration of the p53 gene is most frequent genetic feature human cancer and leads to overexpression altered protein in tumor cell nucleus. Two diagnostic procedures are currently available assess mutations: ( a ) molecular analysis sequence; b immunohistochemical accumulation. We now report third approach, serological analysis. Fifteen % primary breast patients were found have circulating antibodies by immunoprecipitation or immunoblotting. close correlation between presence such bad prognosis as high histological grade absence hormone receptors. Furthermore, we that B-cell response induced two immunodominant regions located at carboxy amino termini protein, outside central mutational hot spot region. These findings suggest analysis, combined with histochemical methods, may be suitable for assessing state patients.

参考文章(21)
S. Benchimol, D. Pim, L. Crawford, Radioimmunoassay of the cellular protein p53 in mouse and human cell lines. The EMBO Journal. ,vol. 1, pp. 1055- 1062 ,(1982) , 10.1002/J.1460-2075.1982.TB01296.X
P. W. Hinds, S. J. Baker, C. A. Finlay, A. J. Levine, R. S. Quartin, B. Vogelstein, E. R. Fearon, Mutant p53 DNA clones from human colon carcinomas cooperate with ras in transforming primary rat cells: a comparison of the "hot spot" mutant phenotypes Cell Growth & Differentiation. ,vol. 1, pp. 571- 580 ,(1990)
David Malkin, Frederick P Li, Louise C Strong, Joseph F Fraumeni Jr, Camille E Nelson, David H Kim, Jayne Kassel, Magdalena A Gryka, Farideh Z Bischoff, Michael A Tainsky, Stephen H Friend, Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms Science. ,vol. 250, pp. 1233- 1238 ,(1990) , 10.1126/SCIENCE.1978757
PeterA Hall, Asim Ray, NicholasR Lemoine, CarolA Midgley, Thomas Krausz, DavidP Lane, p53 immunostaining as a marker of malignant disease in diagnostic cytopathology The Lancet. ,vol. 338, pp. 513- ,(1991) , 10.1016/0140-6736(91)90586-E
A. M. Davidoff, J. D. Iglehart, J. R. Marks, Immune response to p53 is dependent upon p53/HSP70 complexes in breast cancers. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 89, pp. 3439- 3442 ,(1992) , 10.1073/PNAS.89.8.3439
Shoji Mashiyama, Takamasa Kayama, Ryuichi Katakura, Takashi Yoshimoto, Yoshinori Murakami, Takao Sekiya, Kenshi Hayashi, Detection of p53 Gene Mutations in Human Brain Tumors by Single-strand Conformation Polymorphism Analysis of Polymerase Chain Reaction Products Oncogene. ,vol. 5, pp. 1037- 1043 ,(1991) , 10.1007/978-4-431-68150-2_41
J.-H. Kim, T. Takahashi, I. Chiba, J.-G. Park, M. J. Birrer, J. K. Roh, H. D. Lee, J.-P. Kim, J. D. Minna, A. F. Gazdar, Occurrence of p53 Gene Abnormalities in Gastric Carcinoma Tumors and Cells Lines Journal of the National Cancer Institute. ,vol. 83, pp. 938- 943 ,(1991) , 10.1093/JNCI/83.13.938
M Hollstein, D Sidransky, B Vogelstein, C. Harris, p53 mutations in human cancers Science. ,vol. 253, pp. 49- 53 ,(1991) , 10.1126/SCIENCE.1905840